# AURINIA PHARMACEUTICALS INC (AUPH)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/AUPH/

- Reporting holders: 5
- Reported value: $998.1K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [JUNCTURE WEALTH STRATEGIES, LLC](https://holderbook.com/funds/1632866-juncture-wealth-strategies-llc/) | $526.0K | 32,478 | 0.1% | 3 |
| [Acropolis Investment Management, LLC](https://holderbook.com/funds/1318601-acropolis-investment-management-llc/) | $318.3K | 19,657 | 0.0% | 6 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $86.1K | 5,317 | 0.0% | 12 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $54.7K | 3,378 | 0.0% | 12 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $13.0K | 800 | 0.0% | 11 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 5 | $998.1K |
| Q2 2026 | 284 | $1.4B |
| Q1 2026 | 260 | $1.1B |
| Q4 2025 | 259 | $1.2B |
| Q3 2025 | 247 | $766.4M |
| Q2 2025 | 221 | $523.8M |
| Q1 2025 | 214 | $527.2M |
| Q4 2024 | 202 | $555.5M |
| Q3 2024 | 185 | $478.6M |
| Q2 2024 | 173 | $341.2M |
| Q1 2024 | 180 | $318.0M |
| Q4 2023 | 192 | $551.0M |